SEC Form 4 · accession 0001209191-16-154198
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark G Currie
Officer — Chief Scientific Officer
Period of report
Dec 7, 2016
Accepted (ET)
Dec 8, 2016 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Dec 7, 2016 | G | 2,500 | $0.00 | D | 23,058 | D | |
| Class B Common Stock | holding | — | — | — | 685,000 | D |
Table II — derivative securities
No Table II lines on this filing.